NCT04581642View on ClinicalTrials.gov

Nociception-Level (NOL) for the Assessment of Pain in Patient Unable to Self-Report

CompletedOBSERVATIONAL
Enrollment

33

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

August 30, 2021

Study Completion Date

November 30, 2021

Conditions
PainOpioid UseDementiaUnconsciousVentilator Lung
Interventions
DEVICE

PMD200

The NOL technology is comprised of a console and designated finger probe with 4 sensors. The Sensors are Photoplethysmography (PPG) Galvanic Skin Response (GSR), Accelerometer (ACC) and Thermistor (TMP)

Trial Locations (1)

42420

Dorot Netanya Gariatric Medical Center, Netanya

Sponsors
All Listed Sponsors
lead

Medasense Biometrics Ltd

OTHER

NCT04581642 - Nociception-Level (NOL) for the Assessment of Pain in Patient Unable to Self-Report | Biotech Hunter | Biotech Hunter